CG15 Type 1 diabetes in children, young people and adults: NICE guideline

The published NICE clinical guideline on Type 1 diabetes. It is a shorter version that the full guideline and contains the recommendations for health professionals and NHS bodies.

We have updated our guidance on screening for other conditions in children and young people with type 1 diabetes (recommendation 1.3.5.1, pages 6, 28, 87 and 97); we have removed the recommendation to re-test for coeliac disease at least every 3 years after diagnosis. This update follows the development of ‘Coeliac disease: recognition and assessment of coeliac disease’ (NICE clinical guideline 86, 2009).

The changes are as follows, and are shown in the document as greyed out text.

Page 6

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• and at least every 3 years thereafter until transfer to adult services
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Should now read

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Page 28

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• and at least every 3 years thereafter until transfer to adult services
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Should now read

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Page 87

Criterion 6 column one

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• and at least every 3 years thereafter until transfer to adult services
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Should now read

Children and young people with type 1 diabetes should be offered screening for:

• coeliac disease at diagnosis
• thyroid disease at diagnosis and annually thereafter until transfer to adult services
• retinopathy annually from the age of 12 years
• microalbuminuria annually from the age of 12 years.

Criterion 6 column two

a.    A child or young person with type 1 diabetes has it documented in their notes that an offer of a coeliac disease test at diagnosis and at least every 3 years has been made

Should now read

a.    A child or young person with type 1 diabetes has it documented in their notes that an offer of a coeliac disease test at diagnosis has been made

Page 97 Ongoing care

The column ‘Every 3 years’ should be deleted.